August 12, 2025

Structure Therapeutics Inc. (GPCR): Unveiling a 317% Potential Upside for Investors

Structure Therapeutics Inc. (NASDAQ: GPCR) is capturing the attention of investors with its promising pipeline and a remarkable potential upside of 317.34%. This clinical-stage biopharmaceutical company, headquartered in South San..

Artivion, Inc. (AORT) Stock Analysis: Navigating Growth Amidst a 15.3% Revenue Surge in the Medical Devices Sector

Artivion, Inc. (NASDAQ: AORT) has been capturing investor attention as it stands at the cusp of a promising growth trajectory within the healthcare sector. With a market capitalization of $2.03..

Surgery Partners, Inc. (SGRY) Stock Analysis: A 36% Upside Awaits Investors in Healthcare

Surgery Partners, Inc. (NASDAQ: SGRY) is making waves in the healthcare sector, particularly in the medical care facilities industry. Headquartered in Brentwood, Tennessee, this U.S.-based company operates a robust network..

Harmony Biosciences Holdings, Inc. (HRMY): Key Insights into a Promising 45% Upside in the Biotech Sector

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY), a burgeoning name in the biotechnology sector, is capturing attention with its robust pipeline and significant potential upside. As a commercial-stage pharmaceutical company based..

Sotera Health Company (SHC) Stock Analysis: Riding a 13.8% Upside Potential in Healthcare Innovation

Sotera Health Company (NASDAQ: SHC) stands as a notable player in the healthcare sector, focusing on diagnostics and research. With a market capitalization of $3.99 billion, this Ohio-based company is..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Exploring a 23% Potential Upside

For investors seeking exposure in the healthcare sector, U.S. Physical Therapy, Inc. (NYSE: USPH) presents an intriguing opportunity, particularly with a potential upside of 23.21% based on analyst price targets...

Omnicell, Inc. (OMCL) Stock Analysis: Exploring a 42.72% Potential Upside in the Healthcare Sector

Omnicell, Inc. (NASDAQ: OMCL) operates at the intersection of healthcare and technology, providing innovative medication management solutions aimed at improving clinical workflows and patient safety. With a market capitalization of..

Bausch Health Companies Inc. (BHC) Stock Analysis: A Closer Look at Its 6.36% Potential Upside

Bausch Health Companies Inc. (NYSE: BHC), a prominent player in the healthcare industry, has been making waves in the market with a current stock price of $6.66 and a market..

NewAmsterdam Pharma (NAMS): Investor Outlook Reveals a Promising 64.61% Upside Potential

NewAmsterdam Pharma Company N.V. (NAMS) has emerged as a prominent player in the biotechnology sector, attracting investor attention with its promising drug pipeline and significant upside potential. With its headquarters..

Crinetics Pharmaceuticals (CRNX) Stock Analysis: Exploring a Potential 153% Upside in Biotech Innovations

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) stands as a compelling opportunity in the healthcare sector, particularly for investors with a focus on biotechnology. The company, headquartered in San Diego, California, is..

Centessa Pharmaceuticals plc (CNTA) Stock Analysis: Unveiling a 94.66% Potential Upside in Biotech

Investors with an eye for healthcare innovation and potential high returns may find Centessa Pharmaceuticals plc (NASDAQ: CNTA) a compelling opportunity. The UK-based biotechnology company, with a market capitalization of..

10x Genomics, Inc. (TXG) Stock Analysis: Navigating a 21.85% Potential Upside in Healthcare Innovation

10x Genomics, Inc. (NASDAQ: TXG), a pioneering entity in the healthcare sector, specializes in developing advanced life science technology that enables comprehensive biological system analysis. With its headquarters in Pleasanton,..

Novavax, Inc. (NVAX) Stock Analysis: Navigating a 63.67% Potential Upside Amid Biotech Volatility

In the ever-evolving landscape of biotechnology, Novavax, Inc. (NASDAQ: NVAX) stands out with its innovative approach to vaccine development. As a key player in the healthcare sector, Novavax has captured..

Dynavax Technologies Corporation (DVAX) Stock Analysis: Exploring a Potential 121.96% Upside

Dynavax Technologies Corporation (NASDAQ: DVAX) is making waves in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market capitalization of $1.23 billion, Dynavax is..

Viridian Therapeutics, Inc. (VRDN) Investor Outlook: Exploring a Potential 125% Upside

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a dynamic player in the biotechnology sector, has drawn significant attention from investors eager to capitalize on its promising pipeline and substantial growth potential. With..

Acadia Healthcare (ACHC) Stock Analysis: A 74.17% Potential Upside Awaits Investors

Acadia Healthcare Company, Inc. (ACHC) presents an intriguing opportunity for investors within the healthcare sector, particularly those focused on medical care facilities. With a market cap standing at $1.76 billion,..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Strong Revenue Growth and Analyst Confidence Paint a Promising Picture

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), a key player in the healthcare sector, is catching the eye of investors with its impressive revenue growth and positive analyst outlook. With a market..

Zai Lab Limited (ZLAB) Stock Analysis: Unpacking the 63% Potential Upside

For investors navigating the tumultuous waters of the biotechnology sector, Zai Lab Limited (NASDAQ: ZLAB) presents a compelling opportunity. As a Chinese biopharmaceutical company, Zai Lab focuses on pioneering treatments..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Navigating a 54% Potential Upside in the Healthcare Sector

Investors looking for opportunities in the healthcare sector might find GoodRx Holdings, Inc. (NASDAQ: GDRX) an intriguing prospect, especially given its potential upside of 54.25%. With its roots deeply embedded..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Exploring a 17.87% Potential Upside in Healthcare

For investors with a keen eye on the healthcare sector, Pediatrix Medical Group, Inc. (NYSE: MD) presents a compelling opportunity. With a market cap of $1.23 billion, this medical care..

Search

Funds

August 12, 2025

Search

Funds

August 12, 2025

FTSE 100

Funds